Atlas Trials

Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets

Clinical trial NCT03739632 · COMPLETED

Trial details

NCT number
NCT03739632
Sponsor
Zhejiang Huahai Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-11-30
Primary completion
2019-12-18
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.